Our latest episode of the Investing Matters Podcast, featuring Janet Mui, award-winning investment industry commentator, has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksValirx Share News (VAL)

Share Price Information for Valirx (VAL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12.00
Bid: 11.50
Ask: 12.50
Change: 0.25 (2.13%)
Spread: 1.00 (8.70%)
Open: 11.75
High: 12.00
Low: 11.50
Prev. Close: 11.75
VAL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.
13 Jul 22 14:44

IN BRIEF: ValiRx shares jump on breast cancer drug candidate progress

ValiRx PLC - Nuneaton, England-based drug development company - Completes the evaluation of the impact of a peptide drug candidate against triple negative breast cancer. Evaluation concludes there is...

Read more
5 Jul 22 15:51

IN BRIEF:ValiRx gains GBP1.0 million from Turner Pope broker option

ValiRx PLC - Nuneaton, England-based drug development company - Announces that the broker option granted to Turner Pope Investments Ltd has been fully subscribed and raises GBP1.0 million before expen...

Read more
30 Jun 22 17:31

TRADING UPDATES: M&C Saatchi expects to deliver on annual profit

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:...

Read more
30 Jun 22 11:35

AIM WINNERS & LOSERS: Frasers invests in MySale; Kefi keeps license

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday....

Read more
23 Jun 22 16:02

UK shareholder meetings calendar - next 7 days

Friday 24 June AFC Energy PLCGM re fees for non-executive directorsAvast PLCAGMDevolver Digital IncAGMEntain PLCAGMGulf Keystone Petroleum LtdAGMHawkwing PLCAGMInvesco Bond Income Plus LtdAGMLife...

Read more
17 Jun 22 13:55

ValiRx expecting to grant extension of exclusivity to TheoremRx

(Sharecast News) - Cancer therapeutics and women's health-focussed ValiRx updated the market on its proposed sub-licensing agreement with TheoremRx for 'VAL201' on Friday....

Read more
17 Jun 22 10:46

AIM WINNERS & LOSERS: M&C Saatchi pulls Next Fifteen deal support

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday....

Read more
17 Jun 22 10:41

ValiRx shares drop as cancer drug sub-licensing progress stalls

(Alliance News) - ValiRx PLC on Friday said it is expecting to be asked to extend the exclusivity period between itself and TheroemRx Inc regarding the proposed sub-licence of cancer treatment VAL201....

Read more
7 Jun 22 19:03

IN BRIEF: ValiRx widens annual loss as R&D costs climb

ValiRx PLC - Nuneaton, England-based drug development company - Widens pretax loss in 2021 to GBP1.7 million from GBP1.5 million the previous year. Research and development costs rise 32% to GBP303,78...

Read more
23 Mar 22 20:53

TRADING UPDATES: Arecor Therapeutics wins patent approval in US

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:...

Read more
15 Mar 22 17:18

TRADING UPDATES: Amigo heads to vote; UniVision court date pushed back

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:...

Read more
15 Mar 22 10:53

AIM WINNERS & LOSERS: Eco Animal expects earnings below consensus

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday....

Read more
14 Feb 22 22:19

TRADING UPDATES: BioPharma backs Collegium; Eurasia creates Kola

(Alliance News) - The following is a round-up of updates by London-listed companies, issued Monday and not separately reported by Alliance News:...

Read more
5 Jan 22 10:50

AIM WINNERS & LOSERS: AdvancedAdvT buys into M&C Saatchi

AIM WINNERS & LOSERS: AdvancedAdvT buys into M&C Saatchi...

Read more
5 Jan 22 09:21

ValiRx enters agreement and potential sub-license with TheoremRx

ValiRx enters agreement and potential sub-license with TheoremRx...

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.